Uploaded April 2026 | Updated September 2026, 2 weeks ago
It is a pleasure to introduce Dr. T.R. Thirucote, who will be presenting on an exciting and emerging topic in drug delivery innovation.
In this talk, Dr. Thirucote will highlight TesoRx Pharma’s novel neoliposomal drug delivery platform, a versatile technology designed to enhance the performance, targeting, and safety of therapeutic agents across multiple indications.
This innovative platform utilizes a lyophilized powder system that spontaneously forms liposomes upon hydration, enabling improved bioavailability, targeted delivery, and reduced systemic exposure. Applications span areas such as:
Testosterone Replacement Therapy (TRT) – improving absorption and reducing dosing challenges
Oncology (e.g., NMIBC, MPE) – enabling localized, high-efficacy treatment with minimal toxicity
Broader therapeutic areas including ophthalmology, CNS, and metabolic disease
Preclinical and early clinical data demonstrate enhanced efficacy, improved safety profiles, and strong regulatory pathways, positioning this platform as a potential game-changer in drug development.
Join us for this Emery Pharma Speaker Series session to explore how neoliposomal technology is redefining drug delivery and unlocking new therapeutic possibilities.
About Emery Pharma:
Emery Pharma is deeply committed to advancing public health and exclusively focuses on projects that enhance the well-being of both individuals and the environment. As a comprehensive contract research laboratory, Emery Pharma provides extensive support across the entire spectrum of pharmaceutical development, covering small molecule drugs, biologics, biosimilars, gene therapy, botanicals, and more.
Emery Pharma's array of premium services includes analytical and bioanalytical solutions, microbiology and cell biology services, drug and impurity characterization, and comprehensive R&D with cGMP/GLP support. The Emery Pharma team excels in customizing innovative solutions tailored to the unique requirements of each client. They seamlessly oversee the entire process, from initial drug discovery to thorough data analysis and insights generation. Their expertise allows them to tackle scientific challenges proactively, ensuring clients avoid unnecessary setbacks.
Emery Pharma's accomplished chemists and biologists harness state-of-the-art technology, encompassing cutting-edge tools such as high-resolution mass spectrometry (Orbitrap), triple quad LC-MS/MS, GC-MS, preparative HPLC, and 400 MHz multinuclear NMR.
For further details, please don't hesitate to reach out to Emery Pharma at info@emerypharma.com or explore their website at:
emerypharma.com
It is a pleasure to introduce Dr. T.R. Thirucote, who will be presenting on an exciting and emerging topic in drug delivery innovation.
In this talk, Dr. Thirucote will highlight TesoRx Pharma’s novel neoliposomal drug delivery platform, a versatile technology designed to enhance the performance, targeting, and safety of therapeutic agents across multiple indications.
This innovative platform utilizes a lyophilized powder system that spontaneously forms liposomes upon hydration, enabling improved bioavailability, targeted delivery, and reduced systemic exposure. Applications span areas such as:
Testosterone Replacement Therapy (TRT) – improving absorption and reducing dosing challenges
Oncology (e.g., NMIBC, MPE) – enabling localized, high-efficacy treatment with minimal toxicity
Broader therapeutic areas including ophthalmology, CNS, and metabolic disease
Preclinical and early clinical data demonstrate enhanced efficacy, improved safety profiles, and strong regulatory pathways, positioning this platform as a potential game-changer in drug development.
Join us for this Emery Pharma Speaker Series session to explore how neoliposomal technology is redefining drug delivery and unlocking new therapeutic possibilities.
About Emery Pharma:
Emery Pharma is deeply committed to advancing public health and exclusively focuses on projects that enhance the well-being of both individuals and the environment. As a comprehensive contract research laboratory, Emery Pharma provides extensive support across the entire spectrum of pharmaceutical development, covering small molecule drugs, biologics, biosimilars, gene therapy, botanicals, and more.
Emery Pharma's array of premium services includes analytical and bioanalytical solutions, microbiology and cell biology services, drug and impurity characterization, and comprehensive R&D with cGMP/GLP support. The Emery Pharma team excels in customizing innovative solutions tailored to the unique requirements of each client. They seamlessly oversee the entire process, from initial drug discovery to thorough data analysis and insights generation. Their expertise allows them to tackle scientific challenges proactively, ensuring clients avoid unnecessary setbacks.
Emery Pharma's accomplished chemists and biologists harness state-of-the-art technology, encompassing cutting-edge tools such as high-resolution mass spectrometry (Orbitrap), triple quad LC-MS/MS, GC-MS, preparative HPLC, and 400 MHz multinuclear NMR.
For further details, please don't hesitate to reach out to Emery Pharma at info@emerypharma.com or explore their website at:
emerypharma.com
